DD293113A5 - Verfahren zur herstellung von komplexen - Google Patents

Verfahren zur herstellung von komplexen Download PDF

Info

Publication number: DD293113A5
Authority: DD; German Democratic Republic
Prior art keywords: group; formula; cooh; compound; meaning
Prior art date: 1987-04-14

Application number

DD88314659A

Other languages

German (de)

English (en)

Inventor

Michel Schaeffer

Didier Doucet

Bruno Bonnemain

Dominique Meyer

Original Assignee

��@�K@�Kk��

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-04-14

Filing date

1988-04-12

Publication date

1991-08-22

1988-04-12 Application filed by ��@�K@�Kk�� filed Critical ��@�K@�Kk��

1991-08-22 Publication of DD293113A5 publication Critical patent/DD293113A5/de

Links

238000000034 method Methods 0.000 title claims abstract description 15
238000004519 manufacturing process Methods 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 claims abstract description 58
238000002360 preparation method Methods 0.000 claims abstract description 51
239000003446 ligand Substances 0.000 claims abstract description 24
229910021645 metal ion Inorganic materials 0.000 claims abstract description 5
150000002500 ions Chemical class 0.000 claims description 15
125000000217 alkyl group Chemical group 0.000 claims description 14
150000003839 salts Chemical class 0.000 claims description 14
125000002768 hydroxyalkyl group Chemical group 0.000 claims description 11
229910052751 metal Inorganic materials 0.000 claims description 11
239000002184 metal Substances 0.000 claims description 11
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 9
150000001412 amines Chemical class 0.000 claims description 8
238000006243 chemical reaction Methods 0.000 claims description 8
150000002739 metals Chemical class 0.000 claims description 8
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 5
125000002947 alkylene group Chemical group 0.000 claims description 4
150000004985 diamines Chemical class 0.000 claims description 4
LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 claims description 4
229910052747 lanthanoid Inorganic materials 0.000 claims description 4
150000002602 lanthanoids Chemical class 0.000 claims description 4
125000004430 oxygen atom Chemical group O* 0.000 claims description 4
150000001413 amino acids Chemical class 0.000 claims description 3
239000003125 aqueous solvent Substances 0.000 claims description 3
150000007529 inorganic bases Chemical class 0.000 claims description 3
150000007530 organic bases Chemical class 0.000 claims description 3
229910052723 transition metal Inorganic materials 0.000 claims description 3
150000003624 transition metals Chemical class 0.000 claims description 3
XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 claims description 2
239000004952 Polyamide Substances 0.000 claims description 2
229920002647 polyamide Polymers 0.000 claims description 2
125000000896 monocarboxylic acid group Chemical group 0.000 claims 2
125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
239000002872 contrast media Substances 0.000 abstract description 6
229910052740 iodine Inorganic materials 0.000 abstract description 5
239000000126 substance Substances 0.000 abstract description 5
238000001727 in vivo Methods 0.000 abstract description 4
239000003795 chemical substances by application Substances 0.000 abstract description 2
238000002595 magnetic resonance imaging Methods 0.000 abstract description 2
230000003287 optical effect Effects 0.000 abstract description 2
229910021644 lanthanide ion Inorganic materials 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 55
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 41
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 33
239000000203 mixture Substances 0.000 description 32
239000000460 chlorine Substances 0.000 description 29
239000000047 product Substances 0.000 description 26
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 25
239000000741 silica gel Substances 0.000 description 25
229910002027 silica gel Inorganic materials 0.000 description 25
229910052757 nitrogen Inorganic materials 0.000 description 22
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 20
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
239000011541 reaction mixture Substances 0.000 description 17
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
238000004809 thin layer chromatography Methods 0.000 description 16
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
239000012074 organic phase Substances 0.000 description 15
239000007787 solid Substances 0.000 description 15
YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 14
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 14
239000000725 suspension Substances 0.000 description 14
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 13
239000003921 oil Substances 0.000 description 13
-1 sodium nitride Chemical class 0.000 description 13
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
238000001816 cooling Methods 0.000 description 11
238000002844 melting Methods 0.000 description 11
230000008018 melting Effects 0.000 description 11
239000011347 resin Substances 0.000 description 11
229920005989 resin Polymers 0.000 description 11
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 10
229910052688 Gadolinium Inorganic materials 0.000 description 10
229910004298 SiO 2 Inorganic materials 0.000 description 10
229940072033 potash Drugs 0.000 description 10
235000015320 potassium carbonate Nutrition 0.000 description 10
238000001035 drying Methods 0.000 description 9
UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 9
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
239000011734 sodium Substances 0.000 description 8
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
238000001914 filtration Methods 0.000 description 7
230000005291 magnetic effect Effects 0.000 description 7
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 7
KKGHENRRYWRWNB-UHFFFAOYSA-N 2,6-dimethyl-1,4,7,10-tetrazacyclododec-6-ene Chemical compound CC1=NCCNCCNC(CNC1)C KKGHENRRYWRWNB-UHFFFAOYSA-N 0.000 description 6
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 6
CMIHHWBVHJVIGI-UHFFFAOYSA-N gadolinium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[Gd+3].[Gd+3] CMIHHWBVHJVIGI-UHFFFAOYSA-N 0.000 description 6
229910052739 hydrogen Inorganic materials 0.000 description 6
239000002904 solvent Substances 0.000 description 6
238000001228 spectrum Methods 0.000 description 6
ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
235000019647 acidic taste Nutrition 0.000 description 5
229910052786 argon Inorganic materials 0.000 description 5
239000012298 atmosphere Substances 0.000 description 5
238000010668 complexation reaction Methods 0.000 description 5
239000012043 crude product Substances 0.000 description 5
238000001704 evaporation Methods 0.000 description 5
230000008020 evaporation Effects 0.000 description 5
238000001819 mass spectrum Methods 0.000 description 5
239000002244 precipitate Substances 0.000 description 5
238000000746 purification Methods 0.000 description 5
125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 5
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 4
238000005481 NMR spectroscopy Methods 0.000 description 4
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
229940106681 chloroacetic acid Drugs 0.000 description 4
239000010949 copper Substances 0.000 description 4
229910001938 gadolinium oxide Inorganic materials 0.000 description 4
229940075613 gadolinium oxide Drugs 0.000 description 4
239000011521 glass Substances 0.000 description 4
239000001257 hydrogen Substances 0.000 description 4
229920000768 polyamine Polymers 0.000 description 4
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
239000011343 solid material Substances 0.000 description 4
YJCDJROSKJIJMI-UHFFFAOYSA-N 2-[(4-methylphenyl)sulfonyl-[2-[(4-methylphenyl)sulfonyl-[2-(4-methylphenyl)sulfonyloxyethyl]amino]ethyl]amino]ethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCN(S(=O)(=O)C=1C=CC(C)=CC=1)CCN(S(=O)(=O)C=1C=CC(C)=CC=1)CCOS(=O)(=O)C1=CC=C(C)C=C1 YJCDJROSKJIJMI-UHFFFAOYSA-N 0.000 description 3
GYALEQKLBHUZOU-UHFFFAOYSA-N 2-hexyl-1,4,7,10-tetrazacyclododecene Chemical compound CCCCCCC1=NCCNCCNCCNC1 GYALEQKLBHUZOU-UHFFFAOYSA-N 0.000 description 3
229910018072 Al 2 O 3 Inorganic materials 0.000 description 3
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
238000001636 atomic emission spectroscopy Methods 0.000 description 3
238000009833 condensation Methods 0.000 description 3
230000005494 condensation Effects 0.000 description 3
238000010828 elution Methods 0.000 description 3
239000005457 ice water Substances 0.000 description 3
238000002329 infrared spectrum Methods 0.000 description 3
238000001361 intraarterial administration Methods 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
238000003756 stirring Methods 0.000 description 3
238000005406 washing Methods 0.000 description 3
ORZHVTYKPFFVMG-UHFFFAOYSA-N xylenol orange Chemical compound OC(=O)CN(CC(O)=O)CC1=C(O)C(C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C=C(CN(CC(O)=O)CC(O)=O)C(O)=C(C)C=2)=C1 ORZHVTYKPFFVMG-UHFFFAOYSA-N 0.000 description 3
GGKPHYHTHNORAL-UHFFFAOYSA-N 2-[4,7,10-tris(carboxymethyl)-12-methyl-1,4,7,10,13-pentazacyclopentadec-1-yl]acetic acid Chemical compound CC1CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN1 GGKPHYHTHNORAL-UHFFFAOYSA-N 0.000 description 2
PTNYVRLOIWSBGQ-UHFFFAOYSA-N 2-hexyl-1,4,7,10-tetrazacyclododecane Chemical compound CCCCCCC1CNCCNCCNCCN1 PTNYVRLOIWSBGQ-UHFFFAOYSA-N 0.000 description 2
UFYVFYUCDPIIQM-UHFFFAOYSA-N 2-methyl-1,4,7,10,13-pentazacyclopentadecane Chemical compound CC1CNCCNCCNCCNCCN1 UFYVFYUCDPIIQM-UHFFFAOYSA-N 0.000 description 2
QORKHMCXLHXYGI-UHFFFAOYSA-N 2-methyl-1,4,7,10-tetrazacyclododecene Chemical compound CC1=NCCNCCNCCNC1 QORKHMCXLHXYGI-UHFFFAOYSA-N 0.000 description 2
PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 description 2
JJGLDZUABHRMDJ-UHFFFAOYSA-N 4-methyl-n-[2-[(4-methylphenyl)sulfonylamino]propyl]benzenesulfonamide Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)NC(C)CNS(=O)(=O)C1=CC=C(C)C=C1 JJGLDZUABHRMDJ-UHFFFAOYSA-N 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
229910052692 Dysprosium Inorganic materials 0.000 description 2
101000610640 Homo sapiens U4/U6 small nuclear ribonucleoprotein Prp3 Proteins 0.000 description 2
101001110823 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-A Proteins 0.000 description 2
101000712176 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L6-B Proteins 0.000 description 2
102100040374 U4/U6 small nuclear ribonucleoprotein Prp3 Human genes 0.000 description 2
239000002253 acid Substances 0.000 description 2
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
229910052794 bromium Inorganic materials 0.000 description 2
235000011089 carbon dioxide Nutrition 0.000 description 2
239000003054 catalyst Substances 0.000 description 2
229910052801 chlorine Inorganic materials 0.000 description 2
229910052802 copper Inorganic materials 0.000 description 2
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
238000004090 dissolution Methods 0.000 description 2
238000004821 distillation Methods 0.000 description 2
239000012154 double-distilled water Substances 0.000 description 2
DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 2
238000000605 extraction Methods 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 2
239000011630 iodine Substances 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
238000012634 optical imaging Methods 0.000 description 2
229910052763 palladium Inorganic materials 0.000 description 2
229910000027 potassium carbonate Inorganic materials 0.000 description 2
235000011181 potassium carbonates Nutrition 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
239000012429 reaction media Substances 0.000 description 2
238000010992 reflux Methods 0.000 description 2
235000010288 sodium nitrite Nutrition 0.000 description 2
229910052938 sodium sulfate Inorganic materials 0.000 description 2
235000011152 sodium sulphate Nutrition 0.000 description 2
239000004071 soot Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000005292 vacuum distillation Methods 0.000 description 2
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
XRONWEZVNBVWHQ-UHFFFAOYSA-N 1,4,7,10-tetrazacyclododecen-2-ylmethanol Chemical compound OCC1=NCCNCCNCCNC1 XRONWEZVNBVWHQ-UHFFFAOYSA-N 0.000 description 1
YPPDKJJBAIDOLA-UHFFFAOYSA-N 1-(2-hydroxyethylamino)octan-2-ol Chemical compound CCCCCCC(O)CNCCO YPPDKJJBAIDOLA-UHFFFAOYSA-N 0.000 description 1
NLKSLZJFFPKVBQ-UHFFFAOYSA-N 2,3-bis[(4-methylphenyl)sulfonylamino]propanoic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NCC(C(O)=O)NS(=O)(=O)C1=CC=C(C)C=C1 NLKSLZJFFPKVBQ-UHFFFAOYSA-N 0.000 description 1
CYBRBDXWHPQWHU-UHFFFAOYSA-N 2,6-dimethyl-1,4,7,10-tetrakis-(4-methylphenyl)sulfonyl-1,4,7,10-tetrazacyclododecane Chemical compound CC1CN(S(=O)(=O)C=2C=CC(C)=CC=2)CC(C)N(S(=O)(=O)C=2C=CC(C)=CC=2)CCN(S(=O)(=O)C=2C=CC(C)=CC=2)CCN1S(=O)(=O)C1=CC=C(C)C=C1 CYBRBDXWHPQWHU-UHFFFAOYSA-N 0.000 description 1
GTKCLZBVGPBHSG-UHFFFAOYSA-N 2,6-dimethyl-1,4,7,10-tetrazacyclododecane Chemical compound CC1CNCC(C)NCCNCCN1 GTKCLZBVGPBHSG-UHFFFAOYSA-N 0.000 description 1
FBQCPKIRYYALGG-UHFFFAOYSA-N 2-(1,4,7,10-tetrazacyclododecen-2-yl)ethanol Chemical compound OCCC1=NCCNCCNCCNC1 FBQCPKIRYYALGG-UHFFFAOYSA-N 0.000 description 1
XZJUASXMYAARPY-UHFFFAOYSA-N 2-[(2-hydroxyethylamino)methylamino]ethanol Chemical compound OCCNCNCCO XZJUASXMYAARPY-UHFFFAOYSA-N 0.000 description 1
VJDZYMIEDBLSDT-UHFFFAOYSA-N 2-[(4-methylphenyl)sulfonyl-[2-(4-methylphenyl)sulfonyloxyethyl]amino]ethyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCCN(S(=O)(=O)C=1C=CC(C)=CC=1)CCOS(=O)(=O)C1=CC=C(C)C=C1 VJDZYMIEDBLSDT-UHFFFAOYSA-N 0.000 description 1
NMRVEKQKYDNYIO-UHFFFAOYSA-N 2-[4,7,10,13-tetrakis(carboxymethyl)-8-methyl-1,4,7,10,13-pentazacyclopentadec-1-yl]acetic acid Chemical compound CC1CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN1CC(O)=O NMRVEKQKYDNYIO-UHFFFAOYSA-N 0.000 description 1
DWUXICSBEIXBNB-UHFFFAOYSA-N 2-[4,7,10-tris(carboxymethyl)-6-(hydroxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid Chemical compound OCC1CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN1CC(O)=O DWUXICSBEIXBNB-UHFFFAOYSA-N 0.000 description 1
HSXRCEVTMOWCFI-UHFFFAOYSA-N 2-[4,7,10-tris(carboxymethyl)-6-methyl-1,4,7,10-tetrazacyclododec-1-yl]acetic acid Chemical compound CC1CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN1CC(O)=O HSXRCEVTMOWCFI-UHFFFAOYSA-N 0.000 description 1
MDYZHYKKBPMPDR-UHFFFAOYSA-N 2-[4,7-bis(carboxymethyl)-9-(hydroxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid Chemical compound OCC1CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN1 MDYZHYKKBPMPDR-UHFFFAOYSA-N 0.000 description 1
DYRQSXNUQCWPNX-UHFFFAOYSA-N 2-hexyl-1,4,7,10-tetrakis-(4-methylphenyl)sulfonyl-1,4,7,10-tetrazacyclododecane Chemical compound CCCCCCC1CN(S(=O)(=O)C=2C=CC(C)=CC=2)CCN(S(=O)(=O)C=2C=CC(C)=CC=2)CCN(S(=O)(=O)C=2C=CC(C)=CC=2)CCN1S(=O)(=O)C1=CC=C(C)C=C1 DYRQSXNUQCWPNX-UHFFFAOYSA-N 0.000 description 1
102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 description 1
YTCSKODYWQUOKD-UHFFFAOYSA-N 2-methyl-1,4,7,10-tetrazacyclododecane Chemical compound CC1CNCCNCCNCCN1 YTCSKODYWQUOKD-UHFFFAOYSA-N 0.000 description 1
XQKAYTBBWLDCBB-UHFFFAOYSA-N 3,4-diaminobutanoic acid Chemical compound NCC(N)CC(O)=O XQKAYTBBWLDCBB-UHFFFAOYSA-N 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
BDDLHHRCDSJVKV-UHFFFAOYSA-N 7028-40-2 Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O BDDLHHRCDSJVKV-UHFFFAOYSA-N 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
229910052691 Erbium Inorganic materials 0.000 description 1
229910052693 Europium Inorganic materials 0.000 description 1
GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 description 1
RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
YWVLYOLHUZNPRA-UHFFFAOYSA-N S(=O)(=O)(O)O.CC1NCCNCCNC(CNC1)C Chemical compound S(=O)(=O)(O)O.CC1NCCNCCNC(CNC1)C YWVLYOLHUZNPRA-UHFFFAOYSA-N 0.000 description 1
241000872198 Serjania polyphylla Species 0.000 description 1
GKLVYJBZJHMRIY-OUBTZVSYSA-N Technetium-99 Chemical compound [99Tc] GKLVYJBZJHMRIY-OUBTZVSYSA-N 0.000 description 1
229910052771 Terbium Inorganic materials 0.000 description 1
OBBVVOWLWDEBMB-UHFFFAOYSA-N [1,4,7,10-tetrakis-(4-methylphenyl)sulfonyl-1,4,7,10-tetrazacyclododec-2-yl]methanol Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CCN(S(=O)(=O)C=2C=CC(C)=CC=2)CC(CO)N(S(=O)(=O)C=2C=CC(C)=CC=2)CCN(S(=O)(=O)C=2C=CC(C)=CC=2)CC1 OBBVVOWLWDEBMB-UHFFFAOYSA-N 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
235000011114 ammonium hydroxide Nutrition 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
239000012300 argon atmosphere Substances 0.000 description 1
125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
AMEDKBHURXXSQO-UHFFFAOYSA-N azonous acid Chemical class ONO AMEDKBHURXXSQO-UHFFFAOYSA-N 0.000 description 1
229910052788 barium Inorganic materials 0.000 description 1
230000001588 bifunctional effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
229910000024 caesium carbonate Inorganic materials 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000006229 carbon black Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229910017052 cobalt Inorganic materials 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
239000012230 colorless oil Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
229940039227 diagnostic agent Drugs 0.000 description 1
FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
229940043276 diisopropanolamine Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 description 1
OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
210000003608 fece Anatomy 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
229910052733 gallium Inorganic materials 0.000 description 1
229910052732 germanium Inorganic materials 0.000 description 1
GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
238000006698 hydrazinolysis reaction Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
229910052738 indium Inorganic materials 0.000 description 1
APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
229910052746 lanthanum Inorganic materials 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000010871 livestock manure Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
239000011572 manganese Substances 0.000 description 1
239000012528 membrane Substances 0.000 description 1
125000005905 mesyloxy group Chemical group 0.000 description 1
125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
VHJGYLZQOIAGIX-UHFFFAOYSA-N n-[3-hydroxy-2-[(4-methylphenyl)sulfonylamino]propyl]-4-methylbenzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NCC(CO)NS(=O)(=O)C1=CC=C(C)C=C1 VHJGYLZQOIAGIX-UHFFFAOYSA-N 0.000 description 1
238000009206 nuclear medicine Methods 0.000 description 1
238000010534 nucleophilic substitution reaction Methods 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
230000005298 paramagnetic effect Effects 0.000 description 1
125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000002953 preparative HPLC Methods 0.000 description 1
239000001294 propane Substances 0.000 description 1
AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
239000000523 sample Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
238000009987 spinning Methods 0.000 description 1
239000012609 strong anion exchange resin Substances 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
238000012800 visualization Methods 0.000 description 1
239000003643 water by type Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Optics & Photonics (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Magnetic Resonance Imaging Apparatus (AREA)
Paints Or Removers (AREA)

DD88314659A 1987-04-14 1988-04-12 Verfahren zur herstellung von komplexen DD293113A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8705288A FR2614020B1 (fr)	1987-04-14	1987-04-14	Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.

Publications (1)

Publication Number	Publication Date
DD293113A5 true DD293113A5 (de)	1991-08-22

Family

ID=9350106

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD88314659A DD293113A5 (de)	1987-04-14	1988-04-12	Verfahren zur herstellung von komplexen

Country Status (22)

Country	Link
EP (1)	EP0287465B1 (da)
JP (1)	JP2675058B2 (da)
KR (1)	KR880012572A (da)
CN (1)	CN1022411C (da)
AT (1)	ATE85052T1 (da)
AU (1)	AU606146B2 (da)
DD (1)	DD293113A5 (da)
DE (1)	DE3877799T2 (da)
DK (1)	DK170946B1 (da)
ES (1)	ES2053779T3 (da)
FI (1)	FI93830C (da)
FR (1)	FR2614020B1 (da)
GR (1)	GR3007495T3 (da)
HR (1)	HRP920514A2 (da)
HU (1)	HU198501B (da)
IE (1)	IE62582B1 (da)
IL (1)	IL86059A (da)
NO (1)	NO176839C (da)
PT (1)	PT87216B (da)
SI (1)	SI8810742A (da)
YU (1)	YU46691B (da)
ZA (1)	ZA882552B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5059412A (en) *	1984-06-04	1991-10-22	The Dow Chemical Company	Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5064633A (en) *	1984-06-04	1991-11-12	The Dow Chemical Company	Macrocyclic aminophosphonic acid complexes, their formulations and use
US5362476A (en) *	1984-10-18	1994-11-08	Board Of Regents, The University Of Texas System	Alkyl phosphonate polyazamacrocyclic cheates for MRI
US5316757A (en) *	1984-10-18	1994-05-31	Board Of Regents, The University Of Texas System	Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
FR2637895B1 (fr) *	1988-10-14	1992-11-06	Guerbet Sa	Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands
AU617338B2 (en) *	1987-07-16	1991-11-28	Nycomed As	Aminopolycarboxylic acids and derivatives thereof
JP2833766B2 (ja) *	1987-07-16	1998-12-09	ニユコメド・アクシエセルカペト	アミノポリカルボン酸およびその誘導体
US5531978A (en) *	1987-07-16	1996-07-02	Nycomed Imaging As	Aminopolycarboxylic acids and derivatives thereof
GB8719042D0 (en) *	1987-08-12	1987-09-16	Parker D	Conjugate compounds
RU2059642C1 (ru) *	1987-12-24	1996-05-10	Бракко Индустрия Кимика С.п.А	Хелаты гадолиния и способ их получения
GB8801646D0 (en) *	1988-01-26	1988-02-24	Nycomed As	Chemical compounds
GB8923843D0 (en) *	1989-10-23	1989-12-13	Salutar Inc	Compounds
US5446145A (en) *	1990-01-19	1995-08-29	Nycomed Salutar, Inc.	Polychelant compounds
CA2069886A1 (en) *	1989-10-23	1991-04-24	David Love	Multi-site metal chelating agents
US5021409A (en) *	1989-12-21	1991-06-04	Johnson Matthey Plc	Antiviral cyclic polyamines
AU625529B2 (en) *	1989-12-22	1992-07-16	E.R. Squibb & Sons, Inc.	10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes
AU6709390A (en) *	1989-12-22	1991-06-27	E.R. Squibb & Sons, Inc.	10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-tris-carboxymethyl -1,4,7,10-tetraazacyclododecane
US5679810A (en) *	1990-01-19	1997-10-21	Salutar, Inc.	Linear oligomeric polychelant compounds
WO1992017215A1 (en)	1990-03-28	1992-10-15	Nycomed Salutar, Inc.	Contrast media
GB9024208D0 (en) *	1990-11-07	1990-12-19	Salutar Inc	Compounds
DE4035760A1 (de) *	1990-11-08	1992-05-14	Schering Ag	Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
EP0598753B1 (en) *	1991-07-19	1998-03-18	Monsanto Company	Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
CA2072934C (en) *	1991-07-19	2007-08-28	Karl William Aston	Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
AU5019193A (en) *	1992-08-19	1994-03-15	Mallinckrodt Medical, Inc.	Ligands for ga-68 pet heart applications
US6204259B1 (en)	1993-01-14	2001-03-20	Monsanto Company	Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
HUT72671A (en) *	1993-11-26	1996-05-28	Dow Chemical Co	Process for preparing polyazamacrocycles
AU706642B2 (en) *	1994-04-22	1999-06-17	G.D. Searle & Co.	Diagnostic image analysis with metal complexes
EP0846003A1 (en)	1995-08-17	1998-06-10	Monsanto Company	Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
EP0844889A1 (en) *	1995-08-17	1998-06-03	Monsanto Company	Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
JP2003501488A (ja)	1999-06-11	2003-01-14	ネオルックスコーポレイション	骨髄抑制のための高投与量放射性核種錯体
US7094885B2 (en)	1999-07-11	2006-08-22	Neorx Corporation	Skeletal-targeted radiation to treat bone-associated pathologies
EP1390081A2 (en)	2001-01-08	2004-02-25	Neorx Corporation	Therapeutic and diagnostic compounds, compositions, and methods
FR2830253B1 (fr) *	2001-09-28	2005-02-04	Air Liquide	Nouveau procede de preparation de macrocycles azotes c-fonctionnalises et nouveaux intermediaires obtenus
FR2968999B1 (fr)	2010-12-20	2013-01-04	Guerbet Sa	Nanoemulsion de chelate pour irm
WO2016145156A1 (en) *	2015-03-10	2016-09-15	Emory University	Metal tricarbonyl complexes comprising substituted iminodiactic acid ligands and uses as radioisotope tracers
US10709697B2 (en)	2015-07-16	2020-07-14	Emory University	Bis-amines, compositions, and uses related to CXCR4 inhibition
CN106588925B (zh) *	2016-12-05	2018-03-30	天津羲泽润科技有限公司	一种制备1,4,7,10‑四氮杂‑2,6‑吡啶环蕃的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO149961C (no) *	1981-06-01	1984-07-25	Borregaard Ind	Fremgangsmaate for fremstilling av n-(2-hydroksyetyl)-derivater av makrocykliske polyaminer, inneholdende flere nitrogenatomer i 1,4-forhold i ringen
NL194579C (nl) *	1983-01-21	2002-08-05	Schering Ag	Diagnostisch middel.
DE3316703A1 (de) *	1983-05-04	1984-11-08	Schering AG, 1000 Berlin und 4709 Bergkamen	Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
JPS60202869A (ja) *	1984-03-26	1985-10-14	Ajinomoto Co Inc	大環状ポリアミン誘導体及びその用途
US4639365A (en) *	1984-10-18	1987-01-27	The Board Of Regents, The University Of Texas System	Gadolinium chelates as NMR contrast agents
EP0232751B1 (en) *	1986-01-23	1991-09-11	E.R. Squibb & Sons, Inc.	1-substituted-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
GB8603537D0 (en) *	1986-02-13	1986-03-19	Parker D	Conjugate compound
DE3625417C2 (de) *	1986-07-28	1998-10-08	Schering Ag	Tetraazacyclododecan-Derivate
GB8719042D0 (en) *	1987-08-12	1987-09-16	Parker D	Conjugate compounds
GB8719041D0 (en) *	1987-08-12	1987-09-16	Parker D	Conjugate compounds

1987
- 1987-04-14 FR FR8705288A patent/FR2614020B1/fr not_active Expired
1988
- 1988-04-12 PT PT87216A patent/PT87216B/pt not_active IP Right Cessation
- 1988-04-12 ZA ZA882552A patent/ZA882552B/xx unknown
- 1988-04-12 DD DD88314659A patent/DD293113A5/de not_active IP Right Cessation
- 1988-04-12 NO NO881567A patent/NO176839C/no unknown
- 1988-04-13 YU YU74288A patent/YU46691B/sh unknown
- 1988-04-13 IL IL86059A patent/IL86059A/xx not_active IP Right Cessation
- 1988-04-13 IE IE111488A patent/IE62582B1/en not_active IP Right Cessation
- 1988-04-13 ES ES88400895T patent/ES2053779T3/es not_active Expired - Lifetime
- 1988-04-13 DE DE8888400895T patent/DE3877799T2/de not_active Expired - Fee Related
- 1988-04-13 FI FI881708A patent/FI93830C/fi not_active IP Right Cessation
- 1988-04-13 EP EP88400895A patent/EP0287465B1/fr not_active Expired - Lifetime
- 1988-04-13 AT AT88400895T patent/ATE85052T1/de not_active IP Right Cessation
- 1988-04-13 SI SI8810742A patent/SI8810742A/sl unknown
- 1988-04-13 DK DK202788A patent/DK170946B1/da not_active IP Right Cessation
- 1988-04-13 JP JP63089189A patent/JP2675058B2/ja not_active Expired - Lifetime
- 1988-04-13 HU HU881897A patent/HU198501B/hu not_active IP Right Cessation
- 1988-04-13 KR KR1019880004187A patent/KR880012572A/ko not_active Ceased
- 1988-04-14 CN CN88102139A patent/CN1022411C/zh not_active Expired - Fee Related
- 1988-04-14 AU AU14611/88A patent/AU606146B2/en not_active Ceased
1992
- 1992-09-26 HR HRP920514AA patent/HRP920514A2/hr not_active Application Discontinuation
1993
- 1993-03-30 GR GR930400681T patent/GR3007495T3/el unknown

Also Published As

Publication number	Publication date
DE3877799D1 (de)	1993-03-11
DK202788A (da)	1988-10-15
FI881708A0 (fi)	1988-04-13
JP2675058B2 (ja)	1997-11-12
HRP920514A2 (hr)	1994-04-30
AU606146B2 (en)	1991-01-31
HUT47075A (en)	1989-01-30
NO176839B (no)	1995-02-27
FI93830B (fi)	1995-02-28
SI8810742A (en)	1996-08-31
EP0287465A1 (fr)	1988-10-19
ZA882552B (en)	1988-09-27
IE62582B1 (en)	1995-02-08
DE3877799T2 (de)	1993-07-22
PT87216A (pt)	1988-05-01
FR2614020B1 (fr)	1989-07-28
CN1022411C (zh)	1993-10-13
FR2614020A1 (fr)	1988-10-21
IL86059A0 (en)	1988-09-30
EP0287465B1 (fr)	1993-01-27
HU198501B (en)	1989-10-30
DK170946B1 (da)	1996-03-25
IL86059A (en)	1993-01-14
CN88102139A (zh)	1988-10-26
NO881567L (no)	1988-10-17
YU74288A (en)	1990-04-30
IE881114L (en)	1988-10-14
NO176839C (no)	1995-06-14
PT87216B (pt)	1992-07-31
ES2053779T3 (es)	1994-08-01
GR3007495T3 (da)	1993-07-30
ATE85052T1 (de)	1993-02-15
FI93830C (fi)	1995-06-12
DK202788D0 (da)	1988-04-13
YU46691B (sh)	1994-04-05
KR880012572A (ko)	1988-11-28
FI881708L (fi)	1988-10-15
JPH01211573A (ja)	1989-08-24
NO881567D0 (no)	1988-04-12
AU1461188A (en)	1988-10-20

Legal Events

Date	Code	Title	Description
1995-06-22	ENJ	Ceased due to non-payment of renewal fee

Publication	Publication Date	Title
DD293113A5 (de)	1991-08-22	Verfahren zur herstellung von komplexen
DE69807558T2 (de)	2003-01-09	Chelatkomplexe paramagnetischer Metalle mit niedriger Toxizität
DE3855239T2 (de)	1996-10-31	Aminocarbonsäure und Derivate
DE3625417C2 (de)	1998-10-08	Tetraazacyclododecan-Derivate
US5650133A (en)	1997-07-22	Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality
DE69434260T2 (de)	2006-01-19	Hepatobillianische magnetische Resonanz-Kontrastmittel
DE69018615T2 (de)	1995-08-10	Heterocyclische chelatbildende wirkstoffe.
DE69226669T2 (de)	1999-04-15	Neue makrocyclische Stickstoff-Liganden, Verfahren zu ihrer Herstellung, Metallkomplexe, diagnostische und therapeutische Zusammensetzungen
EP0263059A2 (de)	1988-04-06	Amid-Komplexe
EP0648209A1 (de)	1995-04-19	Kontrastmittel für die mr diagnostik
DE3825040A1 (de)	1990-01-25	5- oder 6-ring- enthaltende makrocyclische polyaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE69432022T2 (de)	2003-11-20	Polyazacycloalkane als doppelte chelatbildner
DE69417754T2 (de)	1999-12-23	Chelate als kontrastverbesserende mittel
DE69503055T2 (de)	1998-10-15	Makrozyclische chelante, ihre chelate und verwendungen in diagnostik
DE19849465A1 (de)	2000-04-27	Dimere Ionenpaare, Verfahren zu ihrer Herstellung und ihre Verwendung als Kontrastmittel
WO2001051095A2 (de)	2001-07-19	Paramagnetische dota-derivate, diese enthaltende pharmazeutische mittel, verfahren zu ihrer herstellung und ihre verwendung für das nekrose- und infarkt-mr-imaging
DE69232408T2 (de)	2002-09-19	Aminokarboxylat-Liganden mit substituierten, aromatischen Aminogruppen
DE69810492T2 (de)	2003-11-20	Mehrzähnige imine und ihre metalkomplexe
DE4428874A1 (de)	1996-02-22	Dimere DTPA-Derivate und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
US5972307A (en)	1999-10-26	Dichelants
WO1998048844A2 (de)	1998-11-05	Ionenpaare, verfahren zu ihrer herstellung und ihre verwendung als kontrastmittel
DE3633243A1 (de)	1988-03-31	Phosphonat-komplexe
DE68922686T2 (de)	1995-10-12	Zyklische, Stickstoff enthaltende Liganden, ihre Metallkomplexe, diese enthaltende Diagnostik-Mittel und Verfahren zur Herstellung der Liganden.
EP0730586A1 (de)	1996-09-11	1,4,7,10-tetraazacyclododecan-derivate, deren verwendung, diese enthaltende pharmazeutische mittel und verfahren zu deren herstellung
DE69709700T2 (de)	2002-08-08	Kontrastmittel